Israel Active

Tel Aviv University scientists have developed a low-cost vaccine for all Covid-19 variants that is administered as a nasal spray and can be stored at room temperature. The absence of needles means less stress for patients – a previous TAU study showed high stress made vaccines less effective. (Advanced Science article) (Advanced Science Back cover picture)

Israel’s Beyeonics Vision (see previously) has upgraded its “One” Augmented Reality digital visualization headset, with cutting-edge “invisible” infrared night-vision technology. It means that ophthalmic surgeons can now operate on patients’ eyes without causing discomfort to the patient.   (eye surgery video)

At last, a positive Israel story from the New Scientist. It is known that medical clown reduce stress and anxiety in hospitalized children. Now Israel’s Carmel Medical Center found that medical clowns shorten the time children with pneumonia spend in hospital.

Israel’s OCON Therapeutics (see previously) develops, manufactures and markets women’s health products based on its patented, non-invasive, intrauterine therapy delivery technology. 85% of OCON’s workforce are women. Pipeline treatments include fibroids & abnormal bleeding.

Israel’s DeepDense has developed Plug-AI – smart tools to enhance the digital images produced by other medical companies. DeepDense has teamed up with US firm Spectrum Dynamics Medical to improve the quality of cardiac and spinal images and reduce scan times.

The Prism electrodes-laden cap from Israel’s GrayMatters Health (see previously) has been added to the PTSD treatments offered by two major US clinics - Home Base and Fermata. Prism helps patients control PTSD symptoms by displaying brain activity.

Dr. Idit Maya, Head of the Genomic School at Beilinson Hospital explains how the body need to use different proteins to perform different functions. These proteins can be generated by making changes at the cellular level. In the future, new skills can be taught with the help of biological tools.

Doctors at Israel’s Beilinson Hospital have demonstrated the effectiveness of treating prostate cancer with two doses of high-dose external beam radiation instead of the current five doses. Benefits include less physical and emotional toll, less side effects, and shorter wait times.

Israel’s Alpha Tau Medical (see previously) has treated its first patient with recurrent lung cancer using its innovative Alpha DaRT® alpha-radiation cancer therapy. The WHO reports 2.5 million new lung cancer cases annually and the most cancer-related deaths.

Scientists at Israel’s Weizmann Institute have uncovered how aging cells evade the immune system. The protein PD-L1 stops the immune system from recognizing and destroying aging (senescent / “zombie”) cells. Antibodies to PD-L1 reduced inflammation and numbers of senescent cells.